Amid multiple lawsuits against pharmacy benefit managers, a pair of bills have been filed in the 2026 Missouri legislative ...
New York Magazine on MSNOpinion
Trump is barely trying with his new healthcare plan
The president simply doesn’t care that much about fixing this issue. So why is he bothering to pretend?
Trump’s thinly sketched proposal, amounting to a few paragraphs on a website, calls for redirecting insurance subsidies into individual health-savings accounts, which could be used to purchase ...
A House committee found that CVS Health may have violated federal antitrust laws by threatening independent pharmacies to ...
11/14/2025 Motion to extend the time to file a response from December 1, 2025 to January 15, 2026, submitted to The Clerk. 11/14/2025 Response of Express Scripts, Inc., et al. to motion submitted.
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA ® ...
Express Scripts Inc. notched a partial win after a federal judge dismissed various claims from an independent pharmacy that alleged the company engaged in reimbursement practices that were in ...
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. The stock market pummeled Cigna on Thursday after the company’s leaders revealed that their new ...
Cigna (NYSE:CI) said that its health services division, Evernorth, which includes the pharmacy benefit manager Express Scripts, will eliminate the controversial practice of drug rebates for all of its ...
Cigna's Evernorth division is rolling out a rebate-free model for its pharmacy benefit manager, Express Scripts—meaning one of the industry's "Big Three" is moving away from the oft-criticized ...
One of the largest pharmacy benefits managers in the U.S. is overhauling how millions of its commercial members pay for drugs, in a move that should save consumers money at the pharmacy counter while ...
Express Scripts to expand rebate-free model in 2028. FTC probes PBMs over alleged insulin price inflation. Trump pushes to end the “rebate middleman” system. Cigna Group’s decision to eliminate ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果